Identification of a mesenchymal-related signature associated with clinical prognosis in glioma

Malignant glioma with a mesenchymal (MES) signature is characterized by shorter survival time due to aggressive dissemination and resistance to chemoradiotherapy. Here, this study used the TCGA database as the training set and the CGGA database as the testing set. Consensus clustering was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhengwei, Chen, Jie, Huo, Xiuhao, Zong, Gang, Huang, Kebing, Cheng, Meng, Sun, Libo, Yue, Xiaoyu, Bian, Erbao, Zhao, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148476/
https://www.ncbi.nlm.nih.gov/pubmed/33875619
http://dx.doi.org/10.18632/aging.202886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148476/
https://www.ncbi.nlm.nih.gov/pubmed/33875619
http://dx.doi.org/10.18632/aging.202886

Ejemplares similares